|
KMID : 0545120150250091559
|
|
Journal of Microbiology and Biotechnology
2015 Volume.25 No. 9 p.1559 ~ p.1567
|
|
|
Role of folP1 and folP2 Genes in the Action of Sulfamethoxazole and Trimethoprim Against Mycobacteria
|
|
Tianzhou Liu
Bangxing Wang
Jintao Guo
Yang Zhou
Mugweru Julius
Moses Njire
Yuanyuan Cao
Tian Wu
Zhiyong Liu
Changwei Wang
Yong Xu
Tianyu Zhang
|
|
|
Abstract
|
|
|
|
The combination of trimethoprim (TMP) and sulfamethoxazole (SMX) has been shown to be active against Mycobacterium tuberculosis (Mtb) in clinical tuberculosis (TB) treatment. However, the mechanism of action of TMP-SMX against Mtb is still unknown. To unravel this, we have studied the effect of TMP and SMX by deleting the folP2 gene in Mycobacterium smegmatis (Msm), and overexpressing the Mtb and Msm folP1/2 genes in Msm. Knocking out of the folP2 gene in Msm reduced the minimum inhibitory concentration of SMX 8-fold compared with wild type. Overexpression of the folP1 genes from Mtb and Msm increased the MICs by 4- and 2-fold in Msm for SMX and TMP, respectively. We show a strong correlation between the expression of folP1 and folP2 genes and TMP-SMX resistance in mycobacteria. This suggests that a combination of FolP2 inhibitor and SMX could be used for TB treatment with a better outcome.
|
|
|
KEYWORD
|
|
|
Mycobacteria, sulfamethoxazole, trimethoprim, folP1, folP2
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
  
|